Age group: From 12 years of age
Gender: Male or Female
Duration: Up to 12 months
Compensation: Up to $1,255
About this study:
The purpose of the NextCove study is to evaluate an investigational bivalent vaccine that may protect people from getting sick if they come into contact with the virus that causes COVID-19
and multiple variants, including the Omicron variant. Moderna will be evaluating this investigational vaccine as a booster dose in children and adults to learn more about how it works in the body.
Who can participate?
Participants must be at least 12 years old and have received a COVID-19 vaccine and at least 1 booster dose of a COVID-19 vaccine. The booster doses are not required for participants younger than 18 years o
Where is the study taking place?
The study is being conducted at our facility in Palmetto Medical Plaza.
